AptarGroup, Inc. $ATR Stock Sold by Mountain Pacific Investment Advisers LLC

Mountain Pacific Investment Advisers LLC lessened its holdings in AptarGroup, Inc. (NYSE:ATR) by 3.6% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 121,613 shares of the industrial products company’s stock after selling 4,574 shares during the period. AptarGroup accounts for approximately 2.4% of Mountain Pacific Investment Advisers LLC’s portfolio, making the stock its 9th largest holding. Mountain Pacific Investment Advisers LLC’s holdings in AptarGroup were worth $14,735,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. ProShare Advisors LLC raised its holdings in shares of AptarGroup by 1.0% in the 3rd quarter. ProShare Advisors LLC now owns 211,926 shares of the industrial products company’s stock valued at $25,677,000 after acquiring an additional 2,192 shares in the last quarter. Vise Technologies Inc. bought a new stake in shares of AptarGroup during the 3rd quarter valued at about $306,000. State of Wyoming purchased a new position in shares of AptarGroup during the third quarter worth about $66,000. Choreo LLC grew its holdings in shares of AptarGroup by 23.9% during the third quarter. Choreo LLC now owns 2,699 shares of the industrial products company’s stock worth $327,000 after purchasing an additional 520 shares in the last quarter. Finally, Apollon Wealth Management LLC purchased a new position in shares of AptarGroup during the third quarter worth about $213,000. Hedge funds and other institutional investors own 88.52% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on ATR. Raymond James Financial restated an “outperform” rating and issued a $160.00 price objective on shares of AptarGroup in a research report on Wednesday, July 15th. Bank of America reiterated a “buy” rating on shares of AptarGroup in a research report on Monday. Wells Fargo & Company boosted their price target on shares of AptarGroup from $145.00 to $155.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Deutsche Bank Aktiengesellschaft started coverage on shares of AptarGroup in a report on Wednesday, October 7th. They issued a “buy” rating and a $150.00 price target on the stock. Finally, Weiss Ratings restated a “hold (c)” rating on shares of AptarGroup in a research report on Monday, September 21st. Five research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $164.14.

AptarGroup Stock Performance

NYSE:ATR opened at $142.51 on Wednesday. The company has a market capitalization of $9.03 billion, a price-to-earnings ratio of 26.74, a PEG ratio of 4.45 and a beta of 0.33. The business has a 50 day moving average of $126.22 and a 200 day moving average of $127.19. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.50 and a quick ratio of 1.03. AptarGroup, Inc. has a 1-year low of $110.95 and a 1-year high of $146.91.

AptarGroup (NYSE:ATR) last posted its quarterly earnings results on Thursday, October 29th. The industrial products company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.47 by $0.05. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $980.76 million. AptarGroup had a net margin of 6.69% and a return on equity of 13.11%. The business’s revenue was up 6.0% compared to the same quarter last year. During the same period last year, the firm posted $1.62 earnings per share. On average, sell-side analysts predict that AptarGroup, Inc. will post 5.48 earnings per share for the current fiscal year.

AptarGroup Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 3rd. Stockholders of record on Thursday, November 12th will be paid a $0.50 dividend. This is a positive change from AptarGroup’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Thursday, November 12th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. AptarGroup’s dividend payout ratio is currently 46.60%.

Insider Buying and Selling at AptarGroup

In other AptarGroup news, CEO Gael Touya sold 3,740 shares of the business’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $133.76, for a total value of $500,262.40. Following the completion of the sale, the chief executive officer directly owned 29,102 shares of the company’s stock, valued at $3,892,683.52. The trade was a 11.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Shiela Vinczeller sold 765 shares of the business’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $130.37, for a total transaction of $99,733.05. Following the completion of the sale, the insider directly owned 26,313 shares of the company’s stock, valued at $3,430,425.81. This represents a 2.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.73% of the stock is currently owned by company insiders.

AptarGroup Profile

AptarGroup, Inc (NYSE: ATR) develops and manufactures dispensing, sealing and delivery systems for the pharmaceutical, beauty, personal care, food and beverage markets. Its products are designed to control, protect and dispense a wide range of liquids, creams, lotions, fragrances and other formulations.

The company’s offerings include pumps, valves, closures, aerosol systems and other dispensing components, as well as drug-delivery technologies. Through its pharmaceutical business, Aptar supports nasal, pulmonary, ophthalmic, dermal and injectable applications, serving pharmaceutical and biotechnology companies with components and systems used in prescription, over-the-counter and consumer health products.

Aptar serves customers internationally through manufacturing, research and development and commercial operations across North America, Europe, Asia and other global markets.